Gene interactions and pathways from curated databases and text-mining

◀ Back to RHOA

CRK — RHOA

Pathways - manually collected, often from reviews:

Text-mined interactions from Literome

Tsuda et al., J Biol Chem 2004 : Herein, we report that Crk associates with ERM family proteins ( including ezrin, radixin, and moesin ), activates RhoA , and promotes cell motility toward hyaluronic acid ... In concert with the activation of RhoA by Crk , Crk was found to associate with Rho-GDI, which has been shown to bind to ERMs
Zeidan et al., Cardiovasc Res 2008 (Cardiomegaly) : Leptin induced cardiomyocyte hypertrophy involves selective caveolae and RhoA/ROCK dependent p38 MAPK translocation to nuclei
Shafikhani et al., Cell cycle (Georgetown, Tex.) 2008 : Our data demonstrate that the subcellular localization and the activity of RhoA and citron K, which are essential for early stages of cytokinesis, are not dependent on paxillin, Crk or syntaxin-2
Hanna et al., J Biol Chem 2009 : Here we have demonstrated that mechanical strain dependent induction of the CCN1 gene involves signaling cascades through RhoA mediated actin remodeling and the p38 stress activated protein kinase ( SAPK )
Cariolato et al., J Biol Chem 2011 (MAP Kinase Signaling System) : Our results indicate that AKAP-Lbc can assemble a novel transduction complex containing the RhoA effector PKNa, MLTK, MKK3, and p38a, which integrates signals from a ( 1b ) -ARs to promote RhoA dependent activation of p38a
Chaturvedi et al., Am J Physiol Cell Physiol 2011 (MAP Kinase Signaling System...) : Role of RhoA and its effectors ROCK and mDia1 in the modulation of deformation induced FAK, ERK, p38 , and MLC motogenic signals in human Caco-2 intestinal epithelial cells ... Furthermore, RhoA , ROCK inhibition or RhoA, ROCK1, ROCK2, and mDia1 reduction by siRNA also blocked strain induced FAK-Tyr ( 925 ), p38 , and MLC phosphorylation
Moey et al., J Pharmacol Exp Ther 2011 (Cardiomegaly) : These results demonstrate a potent inhibitory effect of ginseng against leptin induced cardiac hypertrophy, an effect associated with prevention of p115RhoGEF-RhoA/ROCK dependent p38 MAPK activation